LSI is Officially Heading to Singapore — Register for LSI Asia '25 Today

Trusted By The Companies Pioneering What’s Next

Our work
Make Your Biggest
Decisions Data-Driven
Our specialized in-house team has decades of experience evaluating medtech markets and executing custom projects for emerging companies, corporate strategics, consulting and private equity firms, investment banks, and more.
Niche Market Assessment
Assessment of under-treated and under-researched gynecologic procedures for a publicly-traded robotics company
Due Diligence
Diligence on a potential deal in the Personal Protective Equipment (PPE) space for a US Private Equity firm
Competitive Analysis
Analysis of the Urinary Catheters market and landscape for an innovative Original Equipment Manufacturer
Custom Services
Expert Services From
Our Trusted Team
icon
Primary Research

We identify and interview or survey KOLs, patients, and other diverse stakeholders to understand and amalgamate unique perspectives, characterize real world demands, and validate market estimates.
icon
Due Diligence

We conduct objective assessments of acquisitions, investments, and corporate strategies to understand market dynamics, provide a 3rd party analysis of risks and opportunities.
icon
Niche Market Assessments

We evaluate markets and segments of interest in deeper depth to produce custom forecasts, competitive landscape analyses, and insights on driving and limiting forces.
Global medtech market coverage,
available in one platform
Our syndicated market intelligence platform is built by in-house medtech
insiders for global medtech executives, with coverage across all medtech
markets in all major domestic and global geographies
Independent Strategy
Assessment for a Major
Robotics Company
A major publicly traded surgical robotics company needed to understand the volumes for select, under-treated and under-researched gynecologic procedures
scale
01
The Challenge
As improved diagnostics emerge in gynecology, there is a growing demand for safe and effective surgical procedures as an alternative to conventional medical management.
Our client sought to understand the volume of these procedures today (US and worldwide) to validate their R&D strategy to their investors and board.
scale
02
The Solution
We conducted an exhaustive search of public and private resources to understand the trends driving these areas of gynecologic surgery.
To generate estimates, we analyzed relevant epidemiology and treatment rates for the underlying conditions which the target procedures addressed.
Having gathered this information across regions (e.g., Europe, APAC, etc.) we evaluated findings against current solutions, established estimates, and validated them with subject-matter experts.
scale
03
The Result
This expediency, a point of pride for all our custom service engagements, allowed the company to rapidly report to their board and investors. The information was used to validate the proposed strategy and update the company’s investor report.
The company and its board have continued to engage our team for custom services that will generate additional market intelligence to inform new strategic initiatives and R&D investments.
custom services
Additional Cases
primary research Case Study
Research and Modelling on Adoption of Surgical Robotics for Treatment of Select Solid Tumors
We conducted quantitative research with over 350 surgical oncologists to understand their perspectives on the use of robotics. The information was used to inform 5 to 10 year procedure volume projection models and analyst insights, by solid tumor type, that enabled the company to prioritize the deployment of their solutions at the level of clinical indication.
product-market fit Case Study
Market Assessment for an Early Stage Company’s Novel Solution to Quantify Fluid Lost During Surgery
We performed a comprehensive market analysis and produced a report that defined the scale of the problem, a competitive landscape assessment, and a quantification of the market opportunity aligned to various milestones. The deliverables enabled the company and its investors to confidently engage with potential new investors and strategic acquirers.
Methodology
Rigorous, Consistent,
Transparent, Trusted
Our experienced team applies a proven methodology, commensurate with the standards of the innovative and highly-regulated industry we serve.
icon
Rigorous

We apply a breadth of primary and secondary research best practices, coupled with our vetted internal databases and industry relationships to generate reliable, insightful, and actionable intelligence.
icon
Consistent

We understand the headache of reconciling dozens of conflicting methodologies, market definitions, etc. and strive to standardize the process internally and for our clients.
icon
Transparent

We are a team of experienced medtech analysts and industry insiders, and make our methods, expertise, and time accessible to all market intelligence clients with just a call or a click.
icon
Trusted

We are proud to be an independent, objective arbiter trusted by many of the largest medtech, consulting, and financial services organizations across the globe.

Trusted By The Companies Pioneering What’s Next

Work with us

Accelerate your business

We’re here to help you make smarter decisions and form stronger partnerships through curated events, independent market intelligence products and services, and digital-forward media.